Literature DB >> 418446

Experimental barbiturate dependence. I. Barbiturate dependence development in rats by drug-admixed food (DAF) method.

E Tagashira, T Izumi, S Yanaura.   

Abstract

A method for testing a rat's physical-dependence liability to sedaditive-hypnotic agents and for evaluating that dependence was studied by using the method. Rats received phenobarbital- or barbital-admixed food on a graded-increase dosage schedule over 30-40 days. Manifestations of CNS-suppressing action of either drug (e.g., systemic muscle relaxation, motor incoordination, staggering gait, and ptosis) persisted day and night during the drug medication. Twenty-four to 48 h after withdrawal of either drug, abstinence symptoms (e.g., muscle fasciculation, nuchal twitching, vocalization, increased irritability, ataxia, hyperthermia, and clonic-tonic and grand mal-type convulsions) were evidenced in all animals (N = 6), some of which died after convulsions. These withdrawal signs in rats were classified and found to be closely correlated with the magnitude of weight loss during the withdrawal. The calssification provides a basis for quantitatively assessing physical-dependence liability. The data obtained in the present study suggest that rats, like dogs and monkeys, are suitable experimental animals for tests in early stages of dependence liability, and that the administration of drug-admixed food is a useful method of developing dependence on both barbiturate and morphine-type drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418446     DOI: 10.1007/bf00426878

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  [Comparison of development of drug dependence in naive and drug dependence-experienced rats].

Authors:  S Yanaura; E Tagashira
Journal:  Nihon Yakurigaku Zasshi       Date:  1975-03

2.  BARBITURATE WITHDRAWAL CONVULSIONS IN DECEREBELLATE DOGS.

Authors:  C F ESSIG
Journal:  Int J Neuropharmacol       Date:  1964-10

3.  Abstinence syndrome in dogs after chronic barbiturate medication.

Authors:  H F FRASER; H ISBELL
Journal:  J Pharmacol Exp Ther       Date:  1954-11       Impact factor: 4.030

4.  Systematic assessment of tolerance to pentobarbital by pellet implantation.

Authors:  I K Ho
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

5.  The effects of drugs on barbiturate withdrawal convulsions in the rat.

Authors:  P R Norton
Journal:  J Pharm Pharmacol       Date:  1970-10       Impact factor: 3.765

6.  [Screening procedure for barbital type physical dependence liability of psychotropic drugs in mice].

Authors:  H Kaneto; M Koida; F Tsuchie; H Miyagawa
Journal:  Nihon Yakurigaku Zasshi       Date:  1973-09

7.  Evaluation of dependence liability and dependence potential of drugs. Report of a WHO Scientific Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1975

8.  Development of tolerance to and physical dependence on barbiturates in rhesus monkeys.

Authors:  T Yanagita; S Takahashi
Journal:  J Pharmacol Exp Ther       Date:  1970-03       Impact factor: 4.030

9.  Barbiturate withdrawal in white rats.

Authors:  C F Essig
Journal:  Int J Neuropharmacol       Date:  1966-01

10.  A method for bioassay of physical dependence on sedative drugs in dog.

Authors:  B E Jones; J A Prada; W R Martin
Journal:  Psychopharmacology (Berl)       Date:  1976-05-05       Impact factor: 4.530

View more
  3 in total

1.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

2.  Experimental dependence on barbiturates. II. Relationship between drug levels in serum and brain and the development of dependence in rats.

Authors:  E Tagashira; T Izumi; S Yanaura
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

3.  Specific action of tranylcypromine to precipitate barbital withdrawal convulsions.

Authors:  E Tagashira; T Hiramori; T Urano; K Nakao; S Yanaura; Y Kuroiwa
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.